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PiperinterruptumOpiz.andPiperchabaLinn.areherbaceousplantsinthePiperaceaefamily.TheethanolextractofP.interruptum
and P. chaba inhibited ethyl phenylpropiolate-induced ear edema and carrageenan-induced hind paw edema in rats. Both extracts
reduced transudative and granuloma weights as well as body weight gain and thymus weight of the chronic inﬂammatory model
using cotton pellet-induced granuloma formation in rats. Moreover, both extracts exhibited analgesic activity on both early phase
and late phase of formalin test in mice and also showed antipyretic activity on yeast-induced hyperthermia in rats.
1.Introduction
The Piperaceae is a huge family of plants, which has been
extensively used for traditional medicine. In Thailand, P.
interruptumorP. ribesoides Wall.,calledSa-kan,iscommonly
found in the northern and northeastern parts. The stem
has long been used as carminative, antiﬂatulent, and tonic
element [1]. There are few reports on pharmacological
activity of this plant. The ethanol extract of stem showed
larvicidal eﬀect [2] and the methanol extract exhibited
inhibitory activity on acetylcholinesterase enzyme [3].
P. chaba or P. longum Linn. or long pepper has var-
ious Thai local names such as Di-pli, Prik-hang, Dipli-
chueak. In Thai traditional systems of medicine, the dried
mature unripe fruits of this plant ﬁnd wide application as
carminative, element tonic, antidiarrheal, expectorant and
oxytocic for postlabor [4]. The fruit extract of P. chaba
has been shown to exhibit various activities including anti-
inﬂammation [5–7], hepatoprotection [8], cytotoxicity and
antitumor [9], chemoprevention [10], antiangiogenesis [11],
immunomodulation [12], and adipogenesis [13].
The purpose of this study was to evaluate anti-inﬂam-
matory,analgesic,andantipyreticactivitiesofethanolextract
from stem of P. interruptum and fruit of P. chaba in animal
models.
2.MaterialsandMethods
2.1. Plant Materials. Stem of P. interruptum (PI) was col-
lected from Phupan, Sakhonnakhon and fruit of P. chaba2 ISRN Pharmacology
(PC) from Khaosaming, Chanthaburi, Thailand. The certi-
ﬁcations of plant materials were carried out at the herbarium
of Department of Forestry, Bangkok, whereas the herbarium
vouchers have been kept at the herbarium of Southern
Center of Thai Medicinal plant at Faculty of Pharmaceutical
Science, Prince of Songkhla University, Songkhla, Thailand.
SKP 146160901 and SKP 146160301 are voucher numbers of
P. interruptum and P. chaba,r e s p e c t i v e l y .
2.2. Preparation of Plant Extracts. A l lp l a n tm a t e r i a l sw e r e
cleansed using water to reduce microbial load. Next, they
were cut into small pieces and dried at 50◦C, powdered, and
extracted following a similar procedure of Thai traditional
practice. Dried ground plant material (1Kg) was macerated
with 95% ethanol for 3 days, ﬁltered and concentrated to
dryness under pressure. The maceration was repeated twice
andthendriedbyevaporator.ThepercentageyieldsofPIand
PC extracts were calculated as 2.47 and 10.89, respectively.
2.3. Experimental Animals. Male Sprague-Dawley rats
weighing 40–60, 100–120, and 200–250g as well as male
ICR mice weighting 30–40g were obtained from National
Laboratory Animal Center, Nakorn Pathom, Thailand. Six
animals were randomly assigned to each group of control
and treatment. They were kept in a room maintained under
environmental conditions of 25 ± 1◦C and 12h dark-light
cycle. The animals had free access to water and food. Rats
were kept in the experimental facility for 1 week to allow
them to be acclimated prior to dosing. The Animal Ethics
Committee of Faculty of Medicine, Thammasat University,
Pathumthani, Thailand, approved all experimental protocols
(no. 0002/2008). After the experiments, all animals were
sacriﬁced.
2.4. Anti-Inﬂammatory Study
2.4.1. Ethyl-Phenylpropiolate-(EPP-) Induced Ear Edema in
Rats [14]. Male rats weighing 40–60g were used for topical
application of EPP 1mg/20μL/ear to induce edema on the
inner and outer surface of both ears. The test substances
were applied in the same manner in a volume of 20μLp r i o r
to applying the irritants. Control group received acetone
(20μL/ear), and the reference group received 1mg/20μL/ear
of phenylbutazone in acetone. The test group received PI or
PC extract at the dose of 1mg/20μL/ear. The thickness of
each ear was measured with a digital vernier caliper before
and at 15, 30, 60, and 120min after edema induction.
2.4.2. Carrageenan-Induced Paw Edema in Rats [15]. Male
rats weighing 100–120g were divided into ﬁve groups of six
ratseach.ThetestgroupswerereceivedPIorPCextract(300,
600, 1,200mg/kg), aspirin (300mg/kg), and 5% Tween80
(control). The test substances were orally administered 1
hour prior to carrageenan injection. A volume of 0.05mL
of 1% carrageenan in sterile normal saline solution (NSS)
was injected intradermally into the plantar side of the right
hind paw of rat. The edema volumes were determined using
a plethysmometer (model 7140, Ugo Basile, Italy) before and
1, 3, and 5h after carrageenan injection.
2.4.3. Cotton Pellet-Induced Granuloma Formation in Rats
[16]. Male rats of weight range 200–250g were chosen
in this experiment. Two sterilized cotton pellets (20 ±
1mg) were implanted subcutaneously; one on each side
of the abdomen under thiopental anesthesia. The PI or
PC extract (1,200mg/kg), aspirin (300mg/kg), and pred-
nisolone (5mg/kg) were orally administered once daily in
a dosage regimen for 7 days, whereas the control group
received 5% Tween only. On the 8th day after implantation,
rats were anaesthetized with thiopental sodium (50mg/kg,
intraperitoneally). Both cotton pellets and thymus were
dissected, dried at 60◦C for 18h and their dry weight
determined. Change in body weight from the beginning and
the end of experiment was also recorded. The transudative
and granuloma weights were calculated as well as percent
granuloma inhibition of the test drugs.
2.5. Analgesic Study
2.5.1. Formalin Test in Mice [17]. Male ICR mice weighing
30–40g were divided into six groups of six animals each.
Control group received 5% Tween80. Aspirin (300mg/kg)
and morphine (10mg/kg) were used as a reference group. PI
and PC extract were administered at the doses of 300, 600,
and1,200mg/kg.Theformalintestconsistsoftwodistinctive
phases. For the early phase assessment, test substances were
orally administered to male ICR mice 1h, whereas morphine
was injected intraperitoneally 30min before the formalin
injection. Twenty μL of 1% formalin in NSS was injected
subcutaneously into the left dorsal hind paw. Time mice
spent on licking of the injected hind paw was determined
between 0–5min after the formalin injection. In the late
phase, formalin was injected after oral administration of test
substances for 40min, or morphine injection for 10min.
Next, the licking time was determined between 20 and
30min after the formalin injection.
2.6. Antipyretic Study
2.6.1. Yeast-Induced Hyperthermia in Rats [18]. Before
inducing pyrexia, the initial rectal temperature of male rats
weighing 200–250g was recorded using a twelve-channel
electric thermometer (LETICA, model TMP 812 RS, Panlab
S.L., Spain). Next, hyperthermia was induced by subcuta-
neous injection of 1mL/100g body weight of 25% yeast in
NSS. The rectal temperatures were recorded 18h later. Then,
those animals which show a rise in rectal temperature of
morethan1◦Cwereorallyadministered withtestsubstances;
PI and PC extracts were (300, 600, 1,200mg/kg), aspirin
(300mg/kg), and 5% Tween80 (control group). The rectal
temperature of animals was recorded every 30min for 2h
following the treatment.
2.7. Statistical Analysis. Results were expressed as mean ±
standard error of mean (S.E.M.). Statistical signiﬁcance was
determined by one-way analysis of variance (ANOVA) and
post hoc least-signiﬁcant diﬀerence (LSD) test using SPSS
software (version 11.0). The P values less than 0.05 were
considered signiﬁcant.ISRN Pharmacology 3
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Figure 1: Eﬀects of PI extract (a) and PC extract (b) on EPP-
induced ear edema formation in rats. ∗Signiﬁcantly diﬀerent from
the control group, P<0.05.
3. Results
3.1. Anti-Inﬂammatory Activities of Piper interruptum Opiz.
and Piper chaba Linn. The EPP-induced rat ear edema is
suitably a common model for screening and estimating anti-
inﬂammatory activity of test substances. Topical application
of EPP on rat ears produced a marked edema formation
as shown in Figure 1. PI and PC extract at the dose of
1mg/ear signiﬁcantly inhibited the ear edema formation.
As a positive control, phenylbutazone (1mg/ear) exhibited
signiﬁcant inhibitory activity on the ear edema formation at
all determination times.
Next, we used the carrageenan-induced paw edema
model to further conﬁrm the activities of the extracts. As
depicted in Figure 2, PI extract, at doses of 300, 600, and
1,200mg/kg reduced the paw edema at 1, 3, and 5h after
carrageenan injection. Similarly, PC extract, at doses of
1,200mg/kg signiﬁcantly reduced the paw edema at 3 and
5h after carrageenan injection. The positive control aspirin
(300mg/kg) markedly produced signiﬁcant inhibitory eﬀect
of the paw edema at all assessment times.
The cotton pellet-induced granuloma formation in rats
was further conducted to determine whether the extracts
are able to inhibit the chronic inﬂammation. The positive
control group treated with prednisolone (5mg/kg, p.o.),
daily for 7 days elicited a noticeable inhibition on tran-
sudation and granuloma formation (Table 1). In contrast,
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Figure 2: Eﬀects of PI extract (a) and PC extract (b) on
carrageenan-induced paw edema in rats. ∗Signiﬁcantly diﬀerent
from the control group, P<0.05.
aspirin (300mg/kg) did not reduce both parameters. PI
extract at the dose of 1,200mg/kg decreased transudative
weight, whereas PC extract reduced both transudative and
granuloma weights. In addition, PI and PC extracts, similar
to prednisolone, signiﬁcantly decreased the body weight gain
and thymus weight of animals while aspirin did not aﬀect
those parameters (Table 2).
3.2. Analgesic and Antipyretic Activities of Piper interruptum
Opiz. and Piper chaba Linn. The formalin test is an applica-
ble and reliable model of nociception. As shown in Figure 3,
alldosesofPIandPCextracts,aspirin,andmorphineelicited
signiﬁcant inhibitory eﬀect on the formalin test in mice.
Signiﬁcantly, the PI extract had a much smaller eﬀect in the
early phase than the other treatments.
In the antipyretic study, PI extract at doses of 300,
600, 1,200mg/kg and aspirin signiﬁcantly decreased the
rectal temperature of hyperthermia rats at all recorded times
(Figure 4(a)). Likewise, PC extract at the doses of 600 and
1,200mg/kg signiﬁcantly reduced the rectal temperature of
rats as shown in Figure 4(b).4 ISRN Pharmacology
Table 1: Eﬀects of PI and PC extracts on granuloma formation and transudation in cotton pellet-induced granuloma formation in rats.
Dose (mg/kg) Granuloma wet
weight (mg)
Granuloma dry
weight (mg)
Transudative
weight (mg)
Granuloma weight
(mg/mg cotton) GI (%)
Control — 518.4 ±58.19 1 .0 ±8.2 427.4 ±50.23 .5 ±0.4
Prednisolone 5 289.9 ±10.8
∗ 66.6 ±4.7
∗ 223.3 ±8.6
∗ 2.3 ±0.2
∗ 34
Aspirin 300 473.9 ±25.79 9 .2 ±9.2 374.7 ±22.64 .0 ±0.50
PI extract 1,200 349.0 ±30.9
∗ 86.4 ±9.1 262.6 ±24.2
∗ 3.3 ±0.46
PC extract 1,200 253.9 ±15.3
∗ 58.2 ±3.6
∗ 196.7 ±13.0
∗ 1.9 ±0.2
∗ 46
Data represent mean ± S.E.M. (n = 6). ∗Signiﬁcantly diﬀerent from the control group, P<0.05.
GI: granuloma inhibition = (Granuloma weight in test group/Granuloma weight in control group) × 100.
Table 2: Eﬀects of PI and PC extracts on body weight and thymus weight in cotton pellet-induced granuloma formation in rats.
Dose Body weight (g) Dry thymus weight
(mg/kg) Initial Final Gain (mg/100g)
Control — 384.2 ±20.5 392.5 ±20.18 .3 ±2.52 2 .2 ±1.4
Prednisolone 5 384.2 ±20.9 367.5 ±13.3 −16.7 ±10.8
∗ 17.8 ±0.7
∗
Aspirin 300 406.7 ±15.7 399.2 ±13.6 −7.5 ±2.82 0 .0 ±1.0
PI extract 1,200 373.3 ± 9.4 356.7 ±9.4
∗ −16.6 ±6.7
∗ 15.2 ±0.7
∗
PC extract 1,200 384.2 ± 9.9 339.2 ± 13.5
∗ −45.0 ±5.3
∗ 12.6 ±1.4
∗
Data represent mean ± S.E.M. (n = 6). ∗Signiﬁcantly diﬀerent from the control group, P<0.05.
4. Discussion
Results of the present study reveal that ethanolic extracts of
PiperinterruptumOpiz.andPiperchabaLinn.possessesanti-
inﬂammatory, analgesic, and antipyretic activities in animal
models.
During the acute phase of inﬂammation, key inﬂamma-
tory mediators including histamine, serotonin, bradykinin,
and prostaglandin are released in order to promote vasodi-
latation and vascular permeability as well as edema [19].
In the present study, PI and PC extracts showed the
inhibitory eﬀect on the ear edema formation induced by
EPP. This result suggested that PI and PC extracts possessed
anti-inﬂammatory activity by blocking the inﬂammatory
mediators of the acute phase of inﬂammation.
The carrageenan-induced paw edema is considered as a
model of the acute phase of inﬂammation which is widely
used for discovery and investigation of anti-inﬂammatory
drug [15]. Especially, this model is known to be sensitive
to cyclooxygenase inhibitors and has been used to evaluate
the eﬀect of NSAIDs, which involves the inhibition of PGs
synthesis [20]. Paw edema is processed by several inﬂam-
matory mediator released in ordinate sequence. The initial
phase is caused by the release of histamine, serotonin, and
bradykinin and followed by the release of prostaglandins
(PGs) at the 3rd hour and lasts for about 6 hour after carra-
geenan injection [20]. The ﬁnal phase appears to be most
interesting in which the maximal vascular response occurs
with the leukocyte migration to the inﬂamed area [21]. In
the present study, oral administration of PI or PC extract
suppressed the hind paw edema. The signiﬁcant inhibitory
eﬀect of both extracts on carrageenan-induced paw edema
at the 3rd hour suggests that the underlying mechanism of
action of PI and PC extracts may involve blocking of the PGs
synthesis and/or the other inﬂammatory mediators.
Cotton pellet-induced granulation is commonly used
to assess the transudative and proliferative components of
chronic inﬂammation. The subcutaneous implantation of
cotton pellet in rat has been divided into at least three
response phases, transudative phase, exudative phase, and
proliferative phase. The transudative phase is deﬁned as
the increase in wet weight of the pellet that occurs during
ﬁrst 3 hour. An exudative phase is deﬁned as plasma leak-
ing from bloodstream around the granuloma that occurs
between 3 and 72 hour after the implantation of pellet. The
proliferative phase is measured as the increase in dry weight
of the granuloma that occurs between 3 and 6 days after
the implantation [16]. In addition, the implanted material
induces a host inﬂammatory response and modulates the
releaseofinﬂammatorymediatorswhichﬁnallyleadtotissue
proliferation and granular formation [22–24]. NSAIDs such
as aspirin elicit a slight inhibition, whereas steroidal anti-
inﬂammation drugs strongly inhibit both transudative and
proliferative phase of inﬂammation [16]. In this study, simi-
lar to prednisolone, PI and PC extract showed similar eﬀects
on both transudative and proliferative phases and reduced
thebodyweightgainaswellasthethymusweight.Theresults
obtained suggest a mechanism of anti-inﬂammatory activity
of PI and PC extract as steroidal-like eﬀect.
T h ef o r m a l i nt e s te l u c i d a t e sc e n t r a la n dp e r i p h e r a la c t i v -
ities of nociception. The response pattern has two distinct
periods of intensive licking activity, an early response (0–
5min after injection) and a late response (20–30min after
injection). The early phase is due to direct eﬀect of formalinISRN Pharmacology 5
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Figure 3: Eﬀects of PI extract (a) and PC extract (b) on formalin
test in mice. ∗Signiﬁcantly diﬀerent from the control group, P<
0.05.
on nociceptors (noninﬂammatory pain). The late phase
response is development of an inﬂammatory response and
release of analgesic mediators, which reﬂect inﬂammatory
pain [17]. Experimental results have indicated that substance
P and bradykinin participate in the early phase, whereas
histamine, serotonin, bradykinin, and PGs are involved in
the late phase [25]. Our study showed analgesic activity
of PI and PC extracts on both phases of the formalin test
suggestingbothdirectanalgesiceﬀectsonthenociceptorand
an inhibition of inﬂammatory pain. Thus, their mode of
action possibly involves the synthesis and/or release of PGs
and/or other pain mediators.
Fever is provoked by many exogenous substances in
animal models, including bacterial endotoxins and microbe
infection.Exogenouspyrogeninducestheproductionofpro-
inﬂammatory cytokines, such as interleukin-1β (IL-1β), IL-
6, interferon-α (IFN-α), and tumor necrosis factor-α (TNF-
α), which enter hypothalamic circulation and stimulate the
release of local prostaglandins (PGs), thereby resetting the
hypothalamic thermal setpoint [26]. Like aspirin, both PI
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Figure 4: Eﬀects of PI extract (a) and PC extract (b) on yeast-
induced hyperthermia in rats. ∗Signiﬁcantly diﬀerent from the
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andPCextractshowedantipyreticactivitywhichislikelydue
to inhibition of the synthesis and/or release of local PGE2
into the preoptic area of anterior hypothalamus [26, 27].
5. Conclusion
The overall results demonstrate that extracts of Piper inter-
ruptum Opiz. and Piper chaba Linn. have anti-inﬂammatory,
analgesic, and antipyretic activities in laboratory animals.
The results obtained suggest their mechanism of action sim-
ilar to NSAIDs as well as steroid-like eﬀect. Nonetheless, the
precise mechanism and the bioactive principles responsible
for these actions remain to be elucidated.
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